Tumour necrosis factor alpha (TNFα) induces mechanical sensitization of rat masseter muscle 34 nociceptors which takes 2-3 hours to manifest and is mediated through activation of P55 and P75 35 receptors. The present study was undertaken to determine whether TNFα induces nociceptor mechanical 36 sensitization through the release of other algogenic substances such as glutamate, prostaglandin E2 37 (PGE2) and/or nerve growth factor (NGF), which have been shown to induce mechanical sensitization 38 of muscle nociceptors. Masseter muscle homogenate levels of PGE2 and NGF were measured 3 hours 39 after injection of TNFα (1μg) or vehicle control using commercially available kits. Interstitial glutamate 40 concentration was measured after injection of TNFα or vehicle control using a glutamate selective 41 biosensor probe. Diclofenac, a cycloxygenase inhibitor that blocks the synthesis of PGE2, DL-2-amino-42 5-phophonovaleric acid (APV), a competitive NMDA receptor antagonist, and a tyrosine kinase A 43 (TrkA) receptor antibody, which blocks NGF-induced masseter muscle nociceptor sensitization, were 44 employed to assess the contribution of PGE2, glutamate, and NGF to TNFα-induced nociceptor 45 sensitization. PGE2 and glutamate concentrations were significantly elevated 3 hours after TNFα 46 injection into the masseter muscle. Injection of diclofenac partially reversed the TNFα-induced 47 decreases in the mechanical threshold (MT) of masseter muscle nociceptors, while vehicle control, APV 48 and TrkA antibody did not significantly alter nociceptor MT. These results suggest that TNFα-induced 49 mechanical sensitization of masseter muscle nociceptors is mediated in part by increased PGE2 levels. 50
Introduction 56
The mechanisms responsible for chronic muscle pain in conditions such as myofascial 57 temporomandibular disorders and fibromyalgia are not known (Cairns 2010 ; Dworkin and LeResche 58 1992; Hedenberg-Magnusson et al. 1997; Leblebici et al. 2007 ). However, an association between 59 elevated serum and plasma levels of tumour necrosis factor alpha (TNFα), a pro-inflammatory cytokine, 60
and chronic muscle and joint pain has been previously reported (Bazzichi et al. 2007 ; Nordahl et al. 61 2000; Shah et al. 2008; Wang et al. 2008 ). In addition, many patients with chronic muscle pain have so 62 called myofascial "trigger points" which are areas of focal muscle hypertonicities that when palpated 63 reproduce their muscle pain, and TNFα levels appear to be significantly elevated in these regions (Shah 64 et al. 2008) . It is thought that TNFα acts on P55 (TNFR1) and P75 (TNFR2) receptors to produce its 65 pro-nociceptive effects in various tissues (Vandenabeele et al. 1995) . Both P55 and P75 receptors are 66 expressed by trigeminal ganglion neurons that innervate the masseter muscle as well as in the masseter 67 muscle itself (Hakim et al. 2009 ). We have recently shown that intramuscular injection of TNFα causes 68 a prolonged mechanical sensitization of masseter muscle nociceptors which takes 2-3 hours to manifest 69 and is mediated via activation of peripheral P55 and P75 receptors (Hakim et al. 2009 ). However, it is 70 not known whether some of the sensitizing effects of TNFα are mediated indirectly through the release 71 of other nociceptive substances such as nerve growth factor (NGF), prostaglandin E2 (PGE2) and 72 glutamate that have been shown to induce mechanical sensitization of muscle nociceptors (Cairns et TNFα causes a delayed mechanical sensitization of skeletal muscle that appeared to be associated with 79 elevated levels of PGE2, NGF, and neuropeptides, although a cause-effect relationship was not 80 demonstrated in these studies (Schafers et al. 2003 ). In the central nervous system, TNFα also induces 81 release of glutamate through activation of P55 receptors (Hermann et al. 2005 ; Youn et al. 2008 ) and 82 enhances α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) and N-methyl-D-aspartic acid 83 (NMDA) receptor currents as well as phosphorylation of the NR1 subunit of NMDA receptor (Wei et al. 84 2008). A 2-3 times increase muscle interstitial glutamate concentration results in significant 85 sensitization of masseter muscle nociceptors ). These results support the concept that 86
TNFα could be mediating sensitization of masseter muscle nociceptors by inducing release of other 87 algogenic substances. 88
The purpose of this study was to further explore the mechanism of TNFα-induced delayed 89 mechanical sensitization of masseter muscle nociceptors. It was hypothesized that TNFα acts indirectly 90 by inducing the release of NGF, PGE2 and/or glutamate and that these nociceptive mediators are 91 responsible for TNFα-induced masseter muscle sensitization. To test this hypothesis, glutamate 92 concentration was measured by using glutamate-selective biosensor probes, and NGF and PGE2 levels 93
were measured by Enzyme-linked immunosorbent assay (ELISA) after injection of a mechanically 94 sensitizing dose of TNFα (1μg). Εlectrophysiology experiments were performed to assess whether 95 these substances play a functional role in TNFα-induced mechanical sensitization of muscle nociceptors. 96
Diclofenac, a cycloxygenase inhibitor that blocks synthesis of PGE2 (Cashman 1996; Gotzsche 2000) , 97
DL-2-amino-5-phophonovaleric acid (APV), a competitive NMDA receptor antagonist, and a tyrosine 98 kinase A (TrkA) receptor antibody, which blocks NGF-induced masseter muscle nociceptor 99 sensitization, were injected 3 hours after intramuscular injection of TNFα to determine whether these 100
antagonists could reverse TNFα-induced mechanical sensitization. 101 102 which was marked on the overlying skin with a black marker. Muscle tissue was place on dry ice and 113 stored at -70 0 C. Tissues were weighed and homogenised using homogenization buffer (50mM Tris-Hcl 114 PH 7.5, 150mM Nacl, 1% Triton, 0.1% Sodium Dodecyl sulphate, 0.5% Sodium deoxycholate). The 115 average weight of muscle tissue in TNFα and PBS group was 0.20±0.03g and 0.25±0.05g respectively. 116
Samples were centrifuged at 4 0 C for 15 minutes at 15000 rmp. The supernatant of the homogenate was 117 collected and muscle protein concentration was determined using Bradford method (Bradford 1976 Isoflurane (2-2.5%) was used to anesthetise rats. A rectal thermometer was used to measure temperature. 144
The trachea was cannulated and the rat was given artificial respiration using rodent ventilator. The 145 carotid artery was cannulated to monitor blood pressure and to inject pentobarbital (100 mg/kg) to 146 terminate the rat at the end of the experiment. Rat core body temperature, expired CO 2 , heart rate, and 147 blood pressure were monitored throughout the experiment and were kept within the range of 36.8-148
37.1°C, 20-50 mmHg, 300-400 beat/min, and 60-80 mmHg, respectively. The rat's head was placed 149 into a streotaxic frame. The skin, muscle and dura overlying the caudal brainstem was reflected to allow 150 stimulation of brainstem with stimulating electrode. A parylene-coated tungsten-recording electrode was 151 lowered into the trigeminal ganglion to record action potentials from single trigeminal ganglion neurons. 152 A blunt probe was used to mechanically stimulate the masseter muscle as a search stimulus to identify 153 trigeminal ganglion neurons whose afferent fibers had receptive fields within the masseter muscle 154 (Cairns et al. 2001 (Cairns et al. , 2002 . The skin overlying the masseter muscle was pulled and pinch and pressure 155 was applied to it to rule out innervation of the skin (Cairns et al. 2001 (Cairns et al. , 2002 . Masseter afferent fibers 156 projecting to caudal brain stem were identified by the antidromic collision technique. Antidromic action 157 potentials were evoked by stimulation of caudal brain stem with constant electric current. Masseter 158 afferent fibers were mechanically stimulated to evoke orthodromic action potentials. Collision of 159 antidromic and orthodromic action potentials was used to confirm the projection of masseter muscle 160 afferent fibers to the caudal brainstem (Cairns et al. 2001 (Cairns et al. , 2002 . The conduction velocity of afferent 161 fibers was calculated by dividing the distance between stimulating and recording electrodes by the 162 latency of the antidromic action potential. To confirm that the mechanoreceptive field of each fiber was 163 in masseter muscle, fibers were required to discharge in response to either injection of TNFα or 164 hypertonic saline (HS; 1M), which was injected into the masseter muscle at the end of the experiment. 165
Afferent fibers were excluded from further analysis if they failed to discharge in response to injection of 166 at least one of the substances injected into the masseter muscle. The relatively high MT of most afferent 167 fibers coupled to their response to HS, led us to identify these afferent fibers as putative nociceptors. 168
169
Electrophysiology experiments. These experiments were carried out to investigate the role of 170 glutamate, NGF and PGE2 in TNFα-induced masseter muscle nociceptor sensitization. Nociceptors 171 were assigned randomly to receive an injection of either vehicle control (10 µl phosphate buffered 172 saline, n=10), the competitive NMDA receptor antagonist APV (10µl, 10mM or 50mM; n=10 per 173 concentration), the non-steroidal anti-inflammatory drug (NSAID) diclofenac (0.1mg/ml, 10µl; n=7) or 174 an antibody against the high affinity NGF TrkA receptor (2μg/ml, 10µl; n=8) 3 hours after TNFα 175 injection. The investigator (AH) was unaware of the content of the injections. Baseline line mechanical 176 threshold (MT) of nociceptors was measured using an electronic von Frey hair (model 160IC, IITC) 177 every minute for 10 minutes prior to insertion of the catheter needle that contained TNFα (Hakim et al. 178 2009). The baseline MT was determined by averaging 10 consecutive mechanical stimuli. 179
TNFα (Sigma; 1µg in 10µl phosphate buffered saline (PBS), n =10) was injected into the receptor field 180 of the identified fiber and MT was measured after every hour for 10 minutes over 3 hours. Ongoing 
Results. 218

Effect of TNFα 219
In vivo single unit extracellular recording of 52 nociceptors was made. Seven nociceptors, which were 220 not mechanically sensitized by TNFα three hours after injection, were excluded from further analysis. To investigate whether TNFα might be acting to increase prostaglandin levels or alter NMDA receptor 243 activation, we tested the effect of the non-steroidal anti-inflammatory drug diclofenac on TNFα-induced 244 mechanical sensitization at a concentration 0.1 mg/ml; a concentration which also competitively inhibits 245 peripheral NMDA receptors ) and prostaglandin synthesis (Cashman 1996; Gotzsche 246 2000) . This concentration of diclofenac also inhibits prostaglandin synthesis, as demonstrated by our 247 finding that TNFα injection significantly elevated levels of PGE2 as compared to vehicle control and 248 that this TNFα-induced elevation in muscle PGE2 level was attenuated by diclofenac ( Fig.2A) . 249
250
Vehicle control injected at 3 hours after TNFα injection had no significant effect on TNFα-induced 251 mechanical sensitization at 10, 20 or 30 minutes post injection (Fig.2B) . Diclofenac, however, when 252 injected 3 hours after TNFα, partially reversed TNFα-induced mechanical sensitization of masseter 253 muscle nociceptors. A significant effect of diclofenac on relative MT was seen at 10, 20 and 30 minutes 254 after its injection (Fig.2C) . These results suggested that an increase in PGE2 levels contributes to 255
TNFα-induced mechanical sensitization, however, as the concentration of diclofenac employed also 256 inhibits NMDA receptor activation, additional experiments were undertaken to examine the role of 257 glutamate and peripheral NMDA receptor activation in TNFα-induced mechanical sensitization. 258 259
Role of Glutamate and Peripheral NMDA receptors in TNFα-induced Mechanical Sensitization 260
The mean baseline concentration of glutamate in the masseter muscle was 40 ± 10μM (n= 10). Two 261 way repeated measures ANOVA revealed a significant effect of treatment (p<0.05) but not time on 262 glutamate concentration, and there was no significant interaction between time and treatment (p=0.1). 263
Post hoc tests revealed that TNFα significantly elevated the concentration of glutamate compared to 264 vehicle control (Fig.3) . However, as can be seen in Figure 3 , the source of the difference between the 265 two treatment groups was principally due to a decline in interstitial glutamate concentration after 266 injection of vehicle, rather than an increase in glutamate after injection of TNFα. 267
268
Injection of the competitive NMDA receptor antagonist APV (10mM or 50mM) 3 hours after injection 269 of TNFα did not significantly change the MT of masseter muscle nociceptors at 10, 20 and 30 minutes 270 after its injection (p<0.05 one way repeated measures ANOVA) (Fig.4 A,B) . NMDA receptor activation 271 did not appear to contribute significantly to the mechanism of TNFα-induced mechanical sensitization. 272
273
Role of NGF and TrkA receptors in TNFα-induced Mechanical Sensitization 274
TNFα injection did not significantly elevate the level of NGF as compared to vehicle control (Fig.5A) . 275
Injection of TrkA antibody 3 hours after TNFα injection did not significantly reverse TNFα-induced 276 masseter muscle nociceptor sensitization at 10, 20 or 30 minutes after its injection (Fig. 5B ). This result 277
shows that NGF is not playing an important role in TNFα induced masseter muscle nociceptor 278 completely reversed the TNFα− induced increase in PGE2 levels, it is conceivable that other algogenic 321 substances also contribute to TNFα-induced mechanical sensitization of masseter muscle nociceptors. 322
323
Glutamate is an excitatory amino acid that causes sensitization of rat masseter muscle nociceptors 324 through activation of peripheral NMDA receptor (Cairns et al. 2003b . A 200-300% increase in 325 interstitial glutamate concentration of rat masseter muscle from baseline concentration is required to 326 induce sensitization of masseter muscle nociceptors ). In the present study, TNFα 327 increased glutamate concentrations on average by about 6 μM (~15%), which suggests that the increase 328 in glutamate concentration induced by TNFα was likely not great enough to contribute to mechanical 329 sensitization, at least through activation of peripheral NMDA receptors. It should noted that the 330 significant difference in glutamate concentration between TNFα and PBS injections mostly reflected a 331 decrease in glutamate concentration after PBS injection, which we suggest was a result of local dilution 
